Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Anticancer effects of Sargassum pallidum polysaccharide through the modulation of ROS-mediated signaling pathways
Haiyan Wang1, Yinghua Li2, Chao Li3
1Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Abstract:
Sargassum pallidum (Turn.) C. Agardh, a type of edible brown algae, is known for its bioactive polysaccharides that possess a range of health-promoting properties. However, the specific anticancer effects and underlying molecular mechanisms of S. pallidum polysaccharides remain incompletely understood. In this study, the anticancer effects and molecular mechanisms of a polysaccharide, PSP-2, extracted from S. pallidum, were investigated in human hepatocellular carcinoma (HepG2) cells. The results showed that PSP-2 significantly inhibited HepG2 cell proliferation, with treatment at a concentration of 4 mg/mL reducing cell viability to 27 % of the blank control. Further analysis revealed that PSP-2 treatment induced apoptosis, increased reactive oxygen species (ROS) generation, and caused a significant decrease in mitochondrial membrane potential (ΔΨm). Western blotting showed that PSP-2 upregulated the expression of key apoptotic proteins, while suppressing the expression of pro-survival and inflammatory proteins. These findings suggest that PSP-2 exhibit antiproliferative effect through the modulation of ROS-mediated ATM-p53-Caspase and JAK-STAT3/NF-κB signaling pathways. Overall, this study provides novel insights into the mechanisms through which S. pallidum polysaccharides exert anticancer effects, highlighting their potential as a functional food and an adjuvant therapeutic agent for liver cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

